In this month’s Presenting alumni section, we are welcoming Jelena Tica, an inspiring molecular biologist, scientist, traveler. Starting October 1st, she will be working for Johnson & Johnson, on clinical trials testing the Janssen Ad26.CoV2.S COVID-19 Vaccine. Besides her exciting career path, we will also look back at Jelena’s experience as S3 project leader and organizer.
Category: Issue 16
Co-author: Ivana Osredek
Hi everyone! We are continuing with our new topic, where we look at various career paths one can take after studying science. Today we are bringing you consulting, a very interesting career focused on problem solving and strategizing. To get a better sense of what consulting is and what it looks like from the inside, we spoke with our EVO alumni and members Matilda Maleš and Matija Žeško.
Drug interactions 101
Since I started working as a community pharmacist, it has come to my attention that a big part of the general population takes six or more medicines every day, especially the elderly. Although they prepared us for this at university, it still surprised me once I witnessed it in everyday practice. The major problem with polytherapy are drug interactions, which are often neglected, especially in Croatia. The idea of rational pharmacotherapy is just that – to rationalize drug use and consequently assure safer treatments (fewer side effects, minimal risk of sub-dosing or overdosing), less cost to the healthcare system and greater adherence to the therapy; the latter possibly being the most crucial.